SE503224C2 - Bensofuranylimidazol-derivat, förfarande för framställning därav och terapeutiska kompositioner innehållande desamma - Google Patents

Bensofuranylimidazol-derivat, förfarande för framställning därav och terapeutiska kompositioner innehållande desamma

Info

Publication number
SE503224C2
SE503224C2 SE9203824A SE9203824A SE503224C2 SE 503224 C2 SE503224 C2 SE 503224C2 SE 9203824 A SE9203824 A SE 9203824A SE 9203824 A SE9203824 A SE 9203824A SE 503224 C2 SE503224 C2 SE 503224C2
Authority
SE
Sweden
Prior art keywords
compounds
general formula
carbon atoms
alkyl group
hours
Prior art date
Application number
SE9203824A
Other languages
English (en)
Swedish (sv)
Other versions
SE9203824L (sv
SE9203824D0 (sv
Inventor
Jesus Andres Garcia Sevilla
Jose Javier Meana Martinez
Fernando Barturen Fernandez
Fernando Antionio Ge Caballero
Angel Menargues Banos
Rosendo Obach Vidal
Francesc Pla Rodas
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of SE9203824D0 publication Critical patent/SE9203824D0/xx
Publication of SE9203824L publication Critical patent/SE9203824L/xx
Publication of SE503224C2 publication Critical patent/SE503224C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE9203824A 1991-12-27 1992-12-18 Bensofuranylimidazol-derivat, förfarande för framställning därav och terapeutiska kompositioner innehållande desamma SE503224C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919127430A GB9127430D0 (en) 1991-12-27 1991-12-27 Benzofuranylimidazole derivatives

Publications (3)

Publication Number Publication Date
SE9203824D0 SE9203824D0 (sv) 1992-12-18
SE9203824L SE9203824L (sv) 1993-06-28
SE503224C2 true SE503224C2 (sv) 1996-04-22

Family

ID=10706855

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9203824A SE503224C2 (sv) 1991-12-27 1992-12-18 Bensofuranylimidazol-derivat, förfarande för framställning därav och terapeutiska kompositioner innehållande desamma

Country Status (34)

Country Link
US (2) US5310930A (fr)
JP (1) JPH05271223A (fr)
AT (1) AT402071B (fr)
AU (1) AU652877B2 (fr)
BE (1) BE1006226A3 (fr)
CA (1) CA2086137C (fr)
CH (1) CH685344A5 (fr)
DE (1) DE4244342C2 (fr)
DK (1) DK155692A (fr)
DZ (1) DZ1655A1 (fr)
ES (1) ES2049186B1 (fr)
FI (1) FI111365B (fr)
FR (2) FR2685698B1 (fr)
GB (2) GB9127430D0 (fr)
GR (1) GR1001566B (fr)
HK (1) HK27096A (fr)
HU (1) HUT67269A (fr)
IE (1) IE73489B1 (fr)
IN (1) IN180496B (fr)
IT (1) IT1256238B (fr)
LU (1) LU88204A1 (fr)
MA (1) MA22752A1 (fr)
MY (1) MY109729A (fr)
NL (1) NL9202238A (fr)
NO (1) NO300841B1 (fr)
NZ (1) NZ245500A (fr)
OA (1) OA09903A (fr)
PL (3) PL170404B1 (fr)
PT (1) PT101158B (fr)
RU (1) RU2068416C1 (fr)
SE (1) SE503224C2 (fr)
TN (1) TNSN92118A1 (fr)
TW (1) TW226997B (fr)
ZA (1) ZA929736B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
EP1266897A3 (fr) * 1997-12-19 2003-12-03 Eli Lilly And Company Dérivés d'imidazoline hypoglycémiques
ZA9811672B (en) * 1997-12-19 2000-06-19 Lilly Co Eli Hypoglycemic imidazoline compounds.
GB2351082A (en) * 1999-06-18 2000-12-20 Lilly Forschung Gmbh Synthesis of Cyclic Substituted Amidines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH593967A5 (en) * 1971-11-09 1977-12-30 Ciba Geigy Ag Optical brighteners for organic materials - consist of quaternised benzofuranyl or naphthofuranyl benzimidazole cpds.
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
GB2122987B (en) * 1982-06-01 1985-09-25 Zyma Sa (+)-cyanidan-3-ol derivatives and pharmaceutical preparations thereof
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
GB8805628D0 (en) * 1988-03-09 1988-04-07 Erba Farmitalia Hypolipidaemic imidazol-2-yl-derivatives of bicyclic compounds & process for their preparation

Also Published As

Publication number Publication date
PL170404B1 (pl) 1996-12-31
LU88204A1 (fr) 1993-05-17
BE1006226A3 (fr) 1994-06-14
NZ245500A (en) 1994-09-27
AU3049692A (en) 1993-07-01
NO300841B1 (no) 1997-08-04
US5310930A (en) 1994-05-10
PT101158A (pt) 1994-03-31
PL170205B1 (pl) 1996-11-29
FI925755A0 (fi) 1992-12-18
DE4244342A1 (fr) 1993-07-01
DE4244342C2 (de) 2001-04-19
GB9127430D0 (en) 1992-02-19
IE73489B1 (en) 1997-06-04
ES2049186A1 (es) 1994-04-01
CA2086137C (fr) 2005-09-06
MA22752A1 (fr) 1993-07-01
PT101158B (pt) 1999-09-30
CH685344A5 (fr) 1995-06-15
AT402071B (de) 1997-01-27
SE9203824L (sv) 1993-06-28
IT1256238B (it) 1995-11-29
IE922945A1 (en) 1993-06-30
ITMI922954A0 (it) 1992-12-23
DZ1655A1 (fr) 2002-02-17
GB2262739A (en) 1993-06-30
NL9202238A (nl) 1993-07-16
DK155692D0 (da) 1992-12-23
FR2685637B1 (fr) 1994-03-25
CA2086137A1 (fr) 1993-06-28
MY109729A (en) 1997-05-31
HK27096A (en) 1996-02-23
NO925007D0 (no) 1992-12-23
GB9226997D0 (en) 1993-02-17
FR2685698B1 (fr) 1994-03-11
FI111365B (fi) 2003-07-15
FR2685698A1 (fr) 1993-07-02
FR2685637A1 (fr) 1993-07-02
FI925755A (fi) 1993-06-28
TW226997B (fr) 1994-07-21
GR1001566B (el) 1994-05-31
GB2262739B (en) 1995-05-17
NO925007L (no) 1993-06-28
RU2068416C1 (ru) 1996-10-27
TNSN92118A1 (fr) 1993-06-08
ITMI922954A1 (it) 1994-06-23
IN180496B (fr) 1998-02-07
PL170409B1 (pl) 1996-12-31
HUT67269A (en) 1995-03-28
OA09903A (fr) 1994-09-15
ZA929736B (en) 1993-06-14
ES2049186B1 (es) 1994-12-16
US5354769A (en) 1994-10-11
ATA252892A (de) 1996-06-15
JPH05271223A (ja) 1993-10-19
DK155692A (da) 1993-06-28
SE9203824D0 (sv) 1992-12-18
AU652877B2 (en) 1994-09-08
PL297109A1 (en) 1993-09-06

Similar Documents

Publication Publication Date Title
AU727654B2 (en) Tricyclic pyrazole derivative
DE69324140T2 (de) Kondensierte imidazol- und triazolderivate als 5-hta rezeptoragonisten
Castro et al. Synthesis and biological activity of 3-[2-(dimethylamino) ethyl]-5-[(1, 1-dioxo-5-methyl-1, 2, 5-thiadiazolidin-2-yl) methyl]-1H-indole and analogs: agonists for the 5-HT1D receptor
US4517188A (en) 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
JPH0812649A (ja) 新規な（チア）シクロアルキル〔ｂ〕インドール類、それらの製造法及びそれらを含む医薬組成物
NL193541C (nl) 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
SE503224C2 (sv) Bensofuranylimidazol-derivat, förfarande för framställning därav och terapeutiska kompositioner innehållande desamma
US5607957A (en) Imidazole, triazole and tetrazole derivatives
US5510359A (en) Heteroaromatic 5-hydroxytryptamine receptor agonists
Asselin et al. Cycloalkanoindoles. 2. 1-Alkyl-1, 2, 3, 4-tetrahydrocarbazole-1-ethanamines and related compounds. Potential antidepressants
DE69516100T2 (de) Trizyklische Oximether, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
SAIGA et al. Synthesis of 1, 2, 3, 4-tetrahydro-β-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1, 2, 3, 4-tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic acid and its 1-alkylated derivatives
FI78291C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-fenoxi-3-hydroxi-indolyl-alkylamino-3-propanoler.
JPS60112789A (ja) ３−アシルアミノ−４−アルキル−２−アゼチジノン−１−スルホン酸誘導体、その製造方法および該誘導体を含有する薬剤
MXPA98004743A (en) Derivativo de pirazol tricicl
GB2078224A (en) The Preparation of Indolo[2 min ,3 min ;3,4]-pyrido[2,1b]-quinazolin-5-ones

Legal Events

Date Code Title Description
NUG Patent has lapsed